We are live on
!
Find out more
Amneal Pharmaceuticals
AMRX
AMRX
129 hedge funds and large institutions have $756M invested in Amneal Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
84% more call options, than puts
Call options by funds: $875K | Put options by funds: $476K
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.16% less ownership
Funds ownership: 94.38% → 91.22% (-3.2%)
21% less funds holding
Funds holding: 164 → 129 (-35)
51% less capital invested
Capital invested by funds: $1.55B → $756M (-$789M)
57% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 58
Holders
129
Holders Change
-35
Holders Change %
-21.34%
% of All Funds
2.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
42
Reduced
40
Closed
58
Calls
$875K
Puts
$476K
Net Calls
+$399K
Net Calls Change
-$699K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.2M |
| 3 |
Neuberger Berman Group
New York
|
+$8.94M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.89M |
| 5 |
Millennium Management
New York
|
+$5.77M |
